These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 3936211

  • 1. A standardized method for measuring anti-F VIII: C inhibitors in haemophilia A by coagulation inhibition in agarose gel.
    Jorquera JI, Carmona E, Aznar JA, Peiró A, Sánchez-Cuenca JM.
    Thromb Haemost; 1985 Aug 30; 54(2):377-80. PubMed ID: 3936211
    [Abstract] [Full Text] [Related]

  • 2. Development of a new modified Bethesda method for coagulation inhibitors: the Osaka modified Bethesda method.
    Torita S, Suehisa E, Kawasaki T, Toku M, Takeo E, Tomiyama Y, Nishida S, Hidaka Y.
    Blood Coagul Fibrinolysis; 2011 Apr 30; 22(3):185-9. PubMed ID: 21245748
    [Abstract] [Full Text] [Related]

  • 3. Nijmegen-Bethesda assay to measure factor VIII inhibitors.
    Duncan E, Collecutt M, Street A.
    Methods Mol Biol; 2013 Apr 30; 992():321-33. PubMed ID: 23546724
    [Abstract] [Full Text] [Related]

  • 4. [Detection of blood coagulation inhibitors using a modified Lossing-Kasper test].
    Meili EO, Büchter U, von Felten A.
    Schweiz Med Wochenschr; 1986 Oct 25; 116(43):1492-4. PubMed ID: 3097819
    [Abstract] [Full Text] [Related]

  • 5. The type of factor VIII deficient plasma used influences the performance of the Nijmegen modification of the Bethesda assay for factor VIII inhibitors.
    Verbruggen B, Giles A, Samis J, Verbeek K, Mensink E, Novákovà I.
    Thromb Haemost; 2001 Dec 25; 86(6):1435-9. PubMed ID: 11776311
    [Abstract] [Full Text] [Related]

  • 6. Validation of a procedure for potency assessing of a high purity factor VIII concentrate--comparison of different factor VIII coagulant assays and effect of prediluent.
    Mazurier C, Parquet-Gernez A, Goudemand M.
    Thromb Haemost; 1990 Oct 22; 64(2):251-5. PubMed ID: 2125374
    [Abstract] [Full Text] [Related]

  • 7. A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detecting factor VIII:C inhibitors in the haemophilia A population of Canada. Association of Hemophilia Centre Directors of Canada. Factor VIII/IX Subcommittee of Scientific and Standardization Committee of International Society on Thrombosis and Haemostasis.
    Giles AR, Verbruggen B, Rivard GE, Teitel J, Walker I.
    Thromb Haemost; 1998 Apr 22; 79(4):872-5. PubMed ID: 9569207
    [Abstract] [Full Text] [Related]

  • 8. Use of the agarose gel method to identify and quantitate factor VIII:C inhibitors.
    Cassidy PG, Triplett DA, LaDuca FM.
    Am J Clin Pathol; 1985 Jun 22; 83(6):697-706. PubMed ID: 3923823
    [Abstract] [Full Text] [Related]

  • 9. Laboratory identification of factor inhibitors: the perspective of a large tertiary hemophilia center.
    Kershaw G, Jayakodi D, Dunkley S.
    Semin Thromb Hemost; 2009 Nov 22; 35(8):760-8. PubMed ID: 20169512
    [Abstract] [Full Text] [Related]

  • 10. Validation of 4% albumin as a diluent in the Bethesda Assay for FVIII inhibitors.
    Kershaw GW, Chen LS, Jayakodi D, Dunkley SM.
    Thromb Res; 2013 Nov 22; 132(6):735-41. PubMed ID: 24119613
    [Abstract] [Full Text] [Related]

  • 11. Coagulation in an agarose gel and its application to the detection and measurement of factor VIII antibodies.
    Bird P.
    Br J Haematol; 1975 Feb 22; 29(2):329-40. PubMed ID: 1191553
    [Abstract] [Full Text] [Related]

  • 12. Modification of the Bethesda assay for factor VIII or IX inhibitors to improve efficiency.
    Gadarowski JJ, Czapek EE, Ontiveros JD, Pedraza JL.
    Acta Haematol; 1988 Feb 22; 80(3):134-8. PubMed ID: 3143212
    [Abstract] [Full Text] [Related]

  • 13. The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability.
    Verbruggen B, Novakova I, Wessels H, Boezeman J, van den Berg M, Mauser-Bunschoten E.
    Thromb Haemost; 1995 Feb 22; 73(2):247-51. PubMed ID: 7792738
    [Abstract] [Full Text] [Related]

  • 14. [Comparison of modified Bethesda assay and Nijmegen assay in detecting FVII inhibitor in patients with hemophilia A].
    Fan LK, Wang ZW, Hua BL, Su W, Wang SJ, Zhao YQ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Oct 22; 31(5):551-4. PubMed ID: 19968068
    [Abstract] [Full Text] [Related]

  • 15. Factor VIII inhibitors in previously treated haemophilia A patients with a double virus-inactivated plasma derived factor VIII concentrate.
    Peerlinck K, Arnout J, Di Giambattista M, Gilles JG, Laub R, Jacquemin M, Saint-Remy JM, Vermylen J.
    Thromb Haemost; 1997 Jan 22; 77(1):80-6. PubMed ID: 9031454
    [Abstract] [Full Text] [Related]

  • 16. Studies of phospholipid reagents used in coagulation I: some general properties and their sensitivity to factor VIII.
    Barrowcliffe TW, Gray E.
    Thromb Haemost; 1981 Oct 22; 46(3):629-33. PubMed ID: 6797093
    [Abstract] [Full Text] [Related]

  • 17. Agarose gel method: its usefulness in assaying factor VIII inhibitors, evaluating treatment and suggesting a mechanism of action for factor IX concentrates.
    Coots MC, Glueck HI, Miller MA.
    Br J Haematol; 1985 Aug 22; 60(4):735-50. PubMed ID: 3927972
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Laboratory identification of factor inhibitors: an update.
    Kershaw G, Favaloro EJ.
    Pathology; 2012 Jun 22; 44(4):293-302. PubMed ID: 22531341
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.